Shridhar Narayanan

Shridhar, a passionate drug hunter with more than 20 years of drug discovery and development experience in Indian pharmaceutical industry in various therapeutic areas. Shridhar holds a basic degree in Pharmaceutical Sciences from University of Mumbai, a PhD in Pharmacology from The Ohio State University and has post-doctoral experience in Neuropharmacology at the University of California, Los Angeles. Shridhar, a serial entrepreneur, is currently CSO and co-founder of Peptris Technologies Pvt. Ltd., an AI/ML company working towards the discovery and development of new drugs in rare diseases, oncology and inflammation. Shridhar is also the Founder Director, Chairman and Chief Executive Officer of Foundation for Neglected Disease Research (FNDR), a not-for-profit company established in 2014 with a mission to discover and develop drugs for diseases of the developing world. Throughout his career, Shridhar has overseen the Discovery and Development of 1 drug, Enmetazobactam, TBA-7371, ZY-19489 and 15 other clinical candidates in the areas of infection, oncology, diabetes, inflammation and respiratory diseases. He has also executed out-licensing deals with major pharma as well as in-licensing of candidates (NCE/NBE) which are in active development. This has generated up-front revenues in excess of 180 million USD.